Apotea AB (publ) (CHIX:APOTES) Debt-to-Asset : 0.13 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:APOTES Apotea AB (publ) CHIX:APOTES
16 GF Score
Price kr76.83
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Debt-to-Asset?

Apotea AB (publ) CHIX:APOTES 16 Debt-to-Asset is 0.13 as of Jun. 2026. GuruFocus rates CHIX:APOTES with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Apotea AB (publ)'s Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was kr62 Mil. Apotea AB (publ)'s Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was kr218 Mil. Apotea AB (publ)'s Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2026 was kr2,226 Mil. Apotea AB (publ)'s debt to asset for the quarter that ended in Jun. 2026 was 0.13.

Apotea AB (publ)  (CHIX:APOTEs) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Apotea AB (publ) Debt-to-Asset Related Terms

Apotea AB (publ) Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Debt-to-Asset Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
0.14 0.27 0.20 0.15 0.17

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.14 0.17 0.13 0.13

Apotea AB (publ) Debt-to-Asset Competitor Comparison

For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apotea AB (publ) Debt-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Apotea AB (publ)'s Debt-to-Asset falls into.


CHIX:APOTES
16GF Score
Apotea AB (publ) CHIX:APOTES
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Apotea AB (publ)'s Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(82.2 + 248.8) / 1980.5
=0.17

Apotea AB (publ)'s Debt-to-Asset for the quarter that ended in Jun. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(61.7 + 217.6) / 2225.8
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.13 mean?
Apotea AB (publ) (CHIX:APOTES) has a Debt-to-Asset of 0.13 as of Jun. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s Debt-to-Asset too high?
Apotea AB (publ)'s current Debt-to-Asset is 0.13. Overall, Apotea AB (publ) has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Debt-to-Asset compare to competitors?
Apotea AB (publ)'s Debt-to-Asset of 0.13 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Healthcare Providers & Services company?
A good Debt-to-Asset depends on the Healthcare Providers & Services industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Apotea AB (publ) and its competitors. Apotea AB (publ)'s current Debt-to-Asset is 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current Debt-to-Asset of 0.13. The current Debt-to-Asset is 0.13. Apotea AB (publ)'s overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current Debt-to-Asset is 0.13 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
16GF Score

Get the complete analysis for CHIX:APOTES

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr76.83
Price